» Articles » PMID: 33813280

Nuclear PTEN Deficiency and Heterozygous PTEN Loss Have Distinct Impacts on Brain and Lymph Node Size

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2021 Apr 4
PMID 33813280
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Defects in PTEN, a critical tumor suppressor, are associated with tumorigenesis and aberrant organ sizes. It has been shown that heterozygous PTEN loss increases brains and neuron size, while the specific loss of nuclear PTEN has the opposite effect. Here, we investigate the impact of a combination of heterozygous PTEN loss and nuclear PTEN loss on the size of various organs, including the brain, liver, thymus, spleen, and inguinal lymph node. We found that the effect of the combination varies among organs. Notably, the combination of heterozygous PTEN loss and nuclear PTEN loss restored the normal size of brains and neurons. In contrast, the liver's size was unaffected by either single PTEN defects or their combination. Strikingly, the size of the inguinal lymph node was greatly increased due to lymphoma by the combination of the two PTEN defects. These data suggest that nuclear PTEN and non-nuclear PTEN function in an antagonistic manner in the brain while acting synergistically in the inguinal lymph node.

Citing Articles

The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development.

Ma Q, Chen G, Li Y, Guo Z, Zhang X Genes Dis. 2024; 11(5):101021.

PMID: 39006182 PMC: 11245990. DOI: 10.1016/j.gendis.2023.04.041.


Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.

Langdon C Biomolecules. 2023; 13(2).

PMID: 36830628 PMC: 9953540. DOI: 10.3390/biom13020259.


Generating a new mouse model for nuclear PTEN deficiency by a single K13R mutation.

Kato T, Igarashi A, Sesaki H, Iijima M Genes Cells. 2021; 26(12):1014-1022.

PMID: 34661323 PMC: 8678295. DOI: 10.1111/gtc.12902.

References
1.
Chalhoub N, Baker S . PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2008; 4:127-50. PMC: 2710138. DOI: 10.1146/annurev.pathol.4.110807.092311. View

2.
Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi P . Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet. 2001; 27(2):222-4. DOI: 10.1038/84879. View

3.
Kato T, Murata D, Anders R, Sesaki H, Iijima M . Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms. Biochem Biophys Res Commun. 2021; 549:83-90. PMC: 7995232. DOI: 10.1016/j.bbrc.2021.02.093. View

4.
Iijima M, Huang Y, Devreotes P . Temporal and spatial regulation of chemotaxis. Dev Cell. 2002; 3(4):469-78. DOI: 10.1016/s1534-5807(02)00292-7. View

5.
Liaw D, Marsh D, Li J, Dahia P, Wang S, Zheng Z . Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997; 16(1):64-7. DOI: 10.1038/ng0597-64. View